Literature DB >> 1367379

Three-dimensional culture of human tumor cells under standardized medium conditions.

J H Schwachofer1, J Hoogenhout, H B Kal.   

Abstract

The 3-dimensional culture of human tumor spheroids under standardized medium conditions may reveal information on specific biological parameters that could be masked in serum-supplemented media. Spheroids derived from human tumor cells are growth retarded in media free of serum. Ex-Cyte IV is a substance derived from human blood that can be used to improve growth in tissue culture. In this study the growth of spheroids from four different human tumor cell lines was studied when grown in medium free of serum, medium supplemented with varying concentrations Ex-Cyte IV, and medium supplemented with foetal calf serum (FCS). The parameters used for comparisons were growth rate, growth enhancement, clonogenicity and cell cycle distribution. The four cell lines showed different growth rates in serum-free medium, which were increased to different extents when Ex-Cyte IV or FCS were added. The growth enhancing effect induced by Ex-Cyte IV was differently concentration dependent for each cell line. The clonogenicity of cells grown as spheroids in serum-free medium was lower than in spheroids grown in supplemented media. There was no difference in clonogenicity between the differently supplemented media. All four cell lines responded to growth in serum-free medium with a drop in the S-phase and G2M phase. The present study provides a novel approach to the study of human tumor cells in 3-dimensional culture under defined conditions. The human serum derived substance Ex-Cyte IV may provide a method to obtain information on specific biological parameters that could be masked in serum-supplemented media.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1367379     DOI: 10.1007/bf00556296

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  19 in total

1.  Nutrient modification of proliferation and radiation response in EMT6/Ro spheroids.

Authors:  C K Luk; R M Sutherland
Journal:  Int J Radiat Oncol Biol Phys       Date:  1987-06       Impact factor: 7.038

2.  Shedding of mitotic cells from the surface of multicell spheroids during growth.

Authors:  J Landry; J P Freyer; R M Sutherland
Journal:  J Cell Physiol       Date:  1981-01       Impact factor: 6.384

3.  Radiosensitivity of human melanoma spheroids influenced by growth rate.

Authors:  J H Schwachöfer; R P Crooijmans; J Hoogenhout; C R Jerusalem; H B Kal; A G Theeuwes
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-11       Impact factor: 7.038

4.  Radiation response of multicell spheroids--an in vitro tumour model.

Authors:  R M Sutherland; R E Durand
Journal:  Curr Top Radiat Res Q       Date:  1976-01

5.  Multicellular aggregates from human tumor cell lines for radiation studies.

Authors:  J H Schwachöfer; R P Crooijmans; J L Broers; J Hoogenhout; C R Jerusalem; R Jerusalem; H B Kal; G Mungyer
Journal:  Anticancer Res       Date:  1989 Mar-Apr       Impact factor: 2.480

6.  Radiation sensitivity of human ovarian carcinoma cell lines in vitro: effects of growth factors and hormones, basement membrane, and intercellular contact.

Authors:  E K Rofstad; R M Sutherland
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-10       Impact factor: 7.038

7.  Growth fraction as the major determinant of multicellular tumor spheroid growth rates.

Authors:  J M Yuhas; A P Li
Journal:  Cancer Res       Date:  1978-06       Impact factor: 12.701

Review 8.  Multicellular spheroids. A review on cellular aggregates in cancer research.

Authors:  W Mueller-Klieser
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

9.  Properties of cloned human glioblastoma cells. Release of a specific protease.

Authors:  V A Liepkalns; C Icard-Liepkalns; A M Sommer; J P Quigley
Journal:  J Neurol Sci       Date:  1982-12       Impact factor: 3.181

Review 10.  Liquid-overlay culture of cellular spheroids.

Authors:  J Carlsson; J M Yuhas
Journal:  Recent Results Cancer Res       Date:  1984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.